Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biofrontera AG
B8FCurrent price
2.54 EUR
+0.0098 EUR (+0.40%)
Last closed
2.6 EUR
Company
–
ISIN
DE0006046113
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
981 274 EUR
Yield for 12 month
-76.87 %
1Y
3Y
5Y
10Y
15Y
B8F
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; and Belixos, a medical skin care series for irritated and sensitive skin. It has a collaboration and partnership agreement with Maruho Co., Ltd. The company was founded in 1997 and is headquartered in Leverkusen, Germany. Address: Hemmelrather Weg 201, Leverkusen, Germany, 51377
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.97 EURP/E ratio
–Dividend Yield
–Current Year
+32 144 920 EUR
Last Year
+25 654 933 EUR
Current Quarter
+3 701 017 EUR
Last Quarter
+7 425 956 EUR
Current Year
+25 921 072 EUR
Last Year
+20 913 286 EUR
Current Quarter
+2 476 980 EUR
Last Quarter
+5 994 591 EUR
Key Figures B8F
1 year
3 years
5 years
10 years
EBITDA
1 122 615 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
2.38 %
PEG Ratio
–
Return On Equity TTM
-57.22 %
Wall Street Target Price
4.97 EUR
Revenue TTM
28 536 603 EUR
Book Value
0.22 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.7 %
Dividend Yield
–
Gross Profit TTM
20 914 283 EUR
Earnings per share
-0.21 EUR
Diluted Eps TTM
-0.21 EUR
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-30.06 %
Dividend Analytics B8F
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History B8F
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:21
Payout Ratio
–
Last Split Date
14.05.2024
Dividend Date
–
Stock Valuation B8F
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.6803
Price Sales TTM
0.7578
Enterprise Value EBITDA
-2.7362
Price Book MRQ
1.553
Financials B8F
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators B8F
For 52 weeks
2.3 EUR
12.14 EUR
50 Day MA
6.27 EUR
Shares Short Prior Month
–
200 Day MA
8.84 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart